Funded Projects › HORIZON
ENVIROMED · Next generation toolbox for greener pharmaceuticals design & manufacturing towards reduced environmental impact
Pharmaceuticals have undoubtably made our world a better place, ensuring longer and healthier lives. However, pharmaceuticals and their active metabolites are rapidly emerging environmental toxicants. It is thus critical that we fully understand, and mitigate where nec-essary, the environmental impact resulting from their production, use and disposal. In this direction, ENVIROMED addresses two aspects of the environmental impact of pharmaceuticals, a) impact of the processes in manufacturing the compound, and b) impact of the compound itself, during its lifecycle. The project narrows the knowledge gap when it comes to the effect of pharmaceutical compounds, and their derivatives, in the environment as it enables the better understanding the environmental impact of such compounds, throughout their lifecycle. It aims to offer (via extensive monitoring campaigns & scientific studies) information regarding occurrence of pharmaceuticals in the environment, their persistence, environmental fate, and toxicity (via in-vitro & in-vivo models) as well as application of in-silico methods to provide information about the basic risk management and fate prediction in the environment. Brief ideas about toxicity endpoints, available ecotoxicity databases, and expert systems employed for rapid toxicity predictions of ecotoxicity of pharmaceuticals will also be taken into account, in order to have a comprehensive approach to pharmaceuticals' Lifecycle Assessment (LCA). Moreover, the project aims at developing a set of technologies that enable greener and overall, more efficient pharmaceuticals production, which include: a) Green-by-design in-silico drug development; b) Novel sensing to allow reduction of rinsing chemicals and cycles; c) a robust Continuous Biomanufacturing line (CBM), which makes use of AI-enabled process optimisation and prediction, using data assimilation based on chemical sensing and energy disaggregation/monitoring. Training activities and a robust exploitation
Consortium · 19 organisations
RISA SICHERHEITSANALYSEN GMBH
DE · €902,500
MITERA IDIOTIKI GENIKI, MAIEYTIKI,GYNAIKOLOGIKI KAI PAIDIATRIKI KLINIKI ANONYMI ETAIREIA
EL · €408,125
TECHNISCHE UNIVERSITAET WIEN
AT · €1,155,937
UAB METIS BALTIC
LT · €288,125
UNIVERSITAET ULM
DE · €675,000
ETHNICON METSOVION POLYTECHNION
EL · €380,000
PFIZER IRELAND PHARMACEUTICALS
IE · €15,000
CLOUDPHARM PRIVATE COMPANY
EL · €533,375
INNOVATION IN RESEARCH & ENGINEERING SOLUTIONS
BE · €378,750
FRAUNHOFER UK RESEARCH LIMITED
UK
AGILENT TECHNOLOGIES LDA UK LIMITED
UK
CONSIGLIO NAZIONALE DELLE RICERCHE
IT · €552,625
HORIBA EUROPE GMBH
DE · €367,500
ETAIREIA YDREYSEOS KAI APOCHETEFSEOS PROTEYOYSIS ANONIMI ETAIREIA
EL · €312,375
ALPES LASERS SA
CH
RESEARCH CENTER FOR NON DESTRUCTIVE TESTING GMBH
AT · €488,250
NOVO NORDISK A/S
DK · €424,250
CY.R.I.C CYPRUS RESEARCH AND INNOVATION CENTER LTD
CY · €365,000
PLEGMA LABS TECHNOLOGIKES LYSEIS ANONYMOS ETAIRIA
EL · €271,250
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.